Franklin Resources’s AbCellera Biologics ABCL Stock Holding History

Franklin Resources’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.9M	Buy	+1,539,746	New	+$14.6M	﹤0.01%	1001

Other funds holding ABCL

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Franklin Resources's ABCL Position: Q3 2026 in Review

Franklin Resources opened a new position in AbCellera Biologics (ABCL) in Q3 2026: 1,539,746 shares worth $18.9M. The stake represents ﹤0.01% of the portfolio and ranks #1001 among its holdings.

80 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

Franklin Resources held 1,539,746 shares of AbCellera Biologics worth $18.9M as of Q3 2026.
AbCellera Biologics was a new Franklin Resources position in Q3 2026.
AbCellera Biologics made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #1001 holding.
80 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.